Newton Charles W.
Novavax, Inc. · Director
Newton Charles W. is listed in filings as Director at Novavax, Inc.. This profile follows SEC Form 4 activity through Apr 28, 2026, including sale activity and purchase activity. Recent filings connect the profile to Novavax, Inc. (NVAX), Keros Therapeutics, Inc. (KROS), Lyell Immunopharma, Inc. (LYEL), and Coherus Oncology, Inc. (CHRS). The current snapshot covers public activity from Jun 12, 2024 to Apr 28, 2026. Reported amounts are shown as $167.8K to $1.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1.4k136 shares | SellAug 12, 2025 | $10.34 | $12.74 | |
| $1.4k131 shares | SellAug 11, 2025 | $10.53 | $12.74 | |
| $112k200k shares | BuyMar 17, 2025 | $0.5581 | $12.74 |